Windlas Biotech Limited
NSE:WINDLAS.NS
859.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 309.45 | 36.86 | 5.7 | 159.3 | 180.78 | 128.55 | 71.95 |
| Short Term Investments
| 1,734.35 | 1,297.5 | 1,754.56 | 383.25 | 225.86 | 212.41 | 228.53 |
| Cash and Short Term Investments
| 2,043.8 | 1,334.36 | 1,760.26 | 542.55 | 406.64 | 340.96 | 300.48 |
| Net Receivables
| 1,362.77 | 1,168.6 | 1,469.16 | 973.21 | 640.33 | 618.26 | 666.4 |
| Inventory
| 621.89 | 747.38 | 587.1 | 414.61 | 493.17 | 190.27 | 351.81 |
| Other Current Assets
| 284.4 | 285.02 | -0.01 | 12.74 | 780.48 | 673.37 | 120.83 |
| Total Current Assets
| 4,312.86 | 3,535.36 | 3,816.51 | 1,943.11 | 1,680.29 | 1,204.6 | 1,439.52 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1,802.88 | 1,227.01 | 984.68 | 956.68 | 700.64 | 704.52 | 940.69 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 44.68 | 14.84 | 8.81 | 4.82 | 5.52 | 4.42 | 454.85 |
| Goodwill and Intangible Assets
| 44.68 | 14.84 | 8.81 | 4.82 | 5.52 | 4.42 | 454.85 |
| Long Term Investments
| 43.23 | 58.18 | 25.61 | 558.09 | 940.01 | 1,014.51 | 28.51 |
| Tax Assets
| 5.72 | 20.25 | 20.35 | 6.63 | 6.63 | 5.08 | 7.44 |
| Other Non-Current Assets
| 52.69 | 434.11 | 54.15 | -508.1 | 51.79 | 48.67 | 27.86 |
| Total Non-Current Assets
| 1,949.2 | 1,754.39 | 1,093.6 | 1,018.12 | 1,704.59 | 1,777.2 | 1,459.35 |
| Total Assets
| 6,262.06 | 5,289.75 | 4,910.11 | 2,961.23 | 3,384.88 | 2,981.8 | 2,898.87 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1,315.11 | 877.43 | 632.32 | 399.33 | 831.36 | 579.34 | 846.17 |
| Short Term Debt
| 16.23 | 18.67 | 61.93 | 310 | 266.88 | 245.25 | 373.65 |
| Tax Payables
| 0 | 5.91 | 0 | 0 | 0 | 39.96 | 48.76 |
| Deferred Revenue
| 21.43 | 274.86 | 230.57 | -310 | -266.88 | -245.25 | 13.33 |
| Other Current Liabilities
| 364.74 | 41.46 | 15.04 | 534.86 | 421.53 | 382.83 | 197.75 |
| Total Current Liabilities
| 1,717.51 | 1,212.42 | 939.86 | 934.19 | 1,252.89 | 962.17 | 1,430.9 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 20.18 | 31.26 | 4.44 | 13.49 | 22.46 | 73.21 | 181.36 |
| Deferred Revenue Non-Current
| -36.37 | -27.75 | 11.17 | 23.85 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 36.37 | 27.75 | 6.83 | 6.83 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 25.01 | 23.36 | 0.04 | -8.32 | 12.94 | 10.57 | 36.23 |
| Total Non-Current Liabilities
| 45.19 | 54.62 | 22.48 | 35.85 | 35.4 | 83.78 | 217.59 |
| Total Liabilities
| 1,762.7 | 1,267.04 | 962.34 | 970.04 | 1,288.29 | 1,045.95 | 1,648.49 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 29.41 |
| Common Stock
| 103.99 | 104.63 | 108.97 | 64.11 | 64.11 | 64.11 | 55.88 |
| Retained Earnings
| 2,259.72 | 1,763.46 | 1,415.01 | 1,035.95 | 1,141.32 | 980.58 | 340.41 |
| Accumulated Other Comprehensive Income/Loss
| 4,395.37 | 168.44 | 154.32 | 136.22 | 136.25 | 136.25 | 139.1 |
| Other Total Stockholders Equity
| -2,259.72 | 1,986.18 | 2,269.47 | 754.91 | 754.91 | 754.91 | 685.58 |
| Total Shareholders Equity
| 4,499.36 | 4,022.71 | 3,947.77 | 1,991.19 | 2,096.59 | 1,935.85 | 1,250.38 |
| Total Equity
| 4,499.36 | 4,022.71 | 3,947.77 | 1,991.19 | 2,096.59 | 1,935.85 | 1,250.38 |
| Total Liabilities & Shareholders Equity
| 6,262.06 | 5,289.75 | 4,910.11 | 2,961.23 | 3,384.88 | 2,981.8 | 2,898.87 |